Clinical Trial Update: Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating safety, tolerability, and immunogenicity of the V114 pneumococcal vaccine in healthy adults and infants completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infections
• Streptococcus Pneumoniae Infections

Drugs mentioned

• V114 (15-valent pneumococcal conjugate vaccine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Streptococcus Pneumoniae Infection, Pneumococcal Infections | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-04-30